*Program and presenters subject to change. Please check back frequently for updates.
Session Leader: Brittany Gerald – Moderna
### @@@ Jamie Gamerman, JD (she/her/hers) – FDA ### 2123199###Presenter (Remote)###Senior Policy Advisor###FDA###Presenter (Remote): Jamie Gamerman, JD (she/her/hers) – FDA
### she/her/hers @@@ Mary Nwokedi, PharmD – PhRMA ### 2078161###Presenter###Director of Diversity in Clinical Trials ###PhRMA ###Presenter: Mary Nwokedi, PharmD – PhRMA
### @@@ Immo Zdrojewski – Moderna ### 1946111###Presenter###Head Global Regulatory Policy and Regulatory Intelligence###Moderna###Presenter: Immo Zdrojewski – Moderna
### @@@ Jewell Martin, MA, MBA, PMP, RAC – BioMarin Pharmaceuticals, Inc. ### 1946971###Moderator###Director for US Regulatory Policy###BioMarin Pharmaceuticals, Inc.###Moderator: Jewell Martin, MA, MBA, PMP, RAC – BioMarin Pharmaceuticals, Inc.
###Moderator: Amra Racic – Veeva Systems
### @@@ Sally Prawdzik (she/her/hers) – Health Canada ### 2119758###Presenter###Acting Director of Policy and International Programs###Health Canada###Presenter: Sally Prawdzik (she/her/hers) – Health Canada
### she/her/hers @@@ Michelle Tarver, MD, PhD (she/her/hers) – U.S. Food and Drug Administration/ CDRH ### 1052823###Presenter (Remote)###Deputy Center Director, Transformation###U.S. Food and Drug Administration/ CDRH###Presenter (Remote): Michelle Tarver, MD, PhD (she/her/hers) – U.S. Food and Drug Administration/ CDRH
### she/her/hersSession Leader: Jennifer Ng Ain Kin (she/her/hers) – Abbott Laboratories
### she/her/hers @@@ Hillary VanderBand, MBA – Abbott Laboratories ### 1946004###Presenter###Group Manager, Digital Marketing###Abbott Laboratories###Presenter: Hillary VanderBand, MBA – Abbott Laboratories
### @@@ Erik R. Vollebregt – Axon Lawyers ### 535481###Presenter###Partner###Axon Lawyers###Presenter: Erik R. Vollebregt – Axon Lawyers
###